Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

Home

/

NTLA

I

Intellia Therapeutics, Inc. (NTLA)

NGM – Real Time Price. Currency in USD

12.03

+0.01 (0.09%)

Market open: Aug 12, 2026, 10:45 AM EDT

12.04

+0.02 (0.18%)

Previous after-hours: Aug 11, 2026, 7:57 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

68M

58M

36M

52M

Cost of goods sold

-16M

-10M

-9M

-8M

Gross Profit

52M

48M

27M

45M

Operating expenses (excl. COGS)

-493M

-582M

-543M

-503M

Operating Income

-441M

-534M

-515M

-458M

Non-operating income, total

28M

15M

34M

-16M

Pretax income

-413M

-519M

-481M

-474M

Equity in earnings

0

0

-

-

Taxes

0

0

0

0

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-413M

-519M

-481M

-474M

Discontinued operations

0

0

0

0

Net income

-413M

-519M

-481M

-474M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

842M-29.3%

1.19B-8.5%

1.30B-14.4%

1.52B

Total current assets

528M

640M

998M

1.22B

Total non-current assets

314M

551M

303M

303M

Total liabilities

171M-46.5%

319M+27.2%

251M-11.9%

285M

Total current liabilities

104M

111M

115M

127M

Total non-current liabilities

67M

208M

136M

158M

Total equity

671M

872M

1.05B

1.24B

Total liabilities & shareholders' equities

842M

1.19B

1.30B

1.52B

Total debt

93M-55.6%

210M+82.2%

115M-11.7%

131M

Name

2025

2024

2023

2022

Cash from operating activities

-395M

-349M

-394M

-333M

Cash from investing activities

228M

126M

-31M

160M

Cash from financing activities

131M

186M

130M

583M

Free cash flow

-396M-11.6%

-355M+13.1%

-408M-17.7%

-347M